| 02:00 - 02:15 PM |
Opening Remarks. Howard Einspahr.
|
|
| 02:15 - 02:40 PM |
11.04.01 (W0309) |
Wim G. J. Hol. Protein Crystallography in Drug Design: Tropical Diseases and Human Topisomerase I. |
| 02:40 - 03:05 PM |
11.04.02 (W0319) |
Paula M. D. Fitzgerald. HIV Protease Inhibitors: Success Stories for Structure- Based Drug Design. |
| 03:05 - 03:30 PM |
11.04.03 (W0296) |
Ming Luo. Inhibitors of Influenza Virus Neuraminidase. |
| 03:30 - 03:45 PM |
11.04.04 (W0187) |
Amy L. Swain. Crystal Structures of An MHC Class II Molecule, DRA/DRB1*0401, in Complex with Peptidomimetic Inhibitors. et al: David R. Bolin, Robert Crowther, Kouichi Ito, Ursula Kammlott, Gary L. Olson, Zoltan Nagy, Robert Palermo, Ramakanth Sarabu. |
| 03:45 - 04:05 PM |
Coffee Break.
|
|
| 04:05 - 04:30 PM |
11.04.05 (W0333) |
Sherin Abdel-Meguid. Lessons Learned from a Decade of Structure- Based Drug Design. |
| 04:30 - 04:45 PM |
11.04.06 (E0022) |
Jon D. Robertus. Structure- Based Design of RIP Inhibitors Against Ricin and Shiga Toxin. et al: Darcie Miller, Maria Svinth, Xinjian Jan, Arthur F. Monzingo. |
| 04:45 - 05:00 PM |
11.04.07 (W0340) |
Corey Strickland. Structural Studies of Farnesyl Protein Transferase. |
| 05:00 - 05:15 PM |
11.04.08 (W0068) |
Jerry Alexandratos. Structure of the Catalytic Domain of Avian Sarcoma Virus Integrase with Bound HIV-1 IN Inhibitor. et al: Jacek Lubkowski, Fan Yang, Alexander Wlodawer, He Zhao, Terrence Burke, Nouri Neamati, Yves Pommier, George Merkel, Anna Marie Skalka. |
| 05:15 - 05:30 PM |
11.04.09 (W0157) |
Ossama El-Kabbani. Structure- Based Drug Design of Aldose and Aldehyde Reductases. et al: Mark Von Itzstein. |
Last updated: Tue Jul 14 13:32:52 EDT 1998
|
WebGlimpse |
|
| Search: The neighborhood of this page The full archive | |